MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 33 (2) , 219-224
- https://doi.org/10.1124/dmd.104.001354
Abstract
Efflux transporters such as P-glycoprotein and multidrug resistance-associated proteins (MRPs) in the intestinal wall restrict intestinal drug transport. To overcome this limitation for enteral drug absorption, galenical targeting approaches have been proposed for site-specific luminal drug release in segments of the gut, where expression of the respective absorption-limiting transporter is minimal. Therefore, expression of multidrug resistance gene 1 (MDR1) and MRP1-5 was systematically investigated in 10 healthy subjects. Biopsies were taken from different segments of the gastrointestinal tract (from duodenum and terminal ileum, as well as ascending, transverse, descending, and sigmoid colon). Gene expression was investigated by quantitative real-time PCR (TaqMan). MRP3 appeared to be the most abundantly expressed transporter in investigated parts of the human intestine, except for the terminal ileum, where MDR1 showed the highest expression. The ranking of transporter gene expression in the duodenum was MRP3 ≫ MDR1 > MRP2 > MRP5 > MRP4 > MRP1. In the terminal ileum, the ranking order was as follows: MDR1 > MRP3 ≫ MRP1 ≈ MRP5 ≈ MRP4 > MRP2. In all segments of the colon (ascending, transverse, descending, and sigmoid colon), the transporter gene expression showed the following order: MRP3 ≫ MDR1 > MRP4 ≈ MRP5 > MRP1 ≫ MRP2. We have shown, for the first time, systematic site-specific expression of MDR1 and MRP mRNA along the gastrointestinal tract in humans. All transporters showed alterations in their expression levels from the duodenum to sigmoid colon. The most pronounced changes were observed for MRP2, with high levels in the small intestine and hardly any expression in colonic segments. This knowledge may be useful to develop new targeting strategies for enteral drug delivery.This publication has 38 references indexed in Scilit:
- ABC of oral bioavailability: transporters as gatekeepers in the gutGut, 2003
- The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailabilityEuropean Journal of Pharmaceutical Sciences, 2003
- Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individualsArchives of Biochemistry and Biophysics, 2002
- Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis ratsEuropean Journal of Pharmaceutical Sciences, 2002
- ABC transporters in lipid transportBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic AnionsMolecular Pharmacology, 2000
- ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)Journal of Biological Chemistry, 2000
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlationBritish Journal of Pharmacology, 1996
- Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse intestineBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995